Connect Biopharma Holdings (CNTB) Non-Current Deffered Revenue (2023 - 2024)
Connect Biopharma Holdings' Non-Current Deffered Revenue came in at $632,000 for Q4 2024, up 56.0% from $405,000 a year earlier.
Powered by 
Analysis
Connect Biopharma Holdings (CNTB) Non-Current Deffered Revenue (2023 - 2024) Analysis & Trends
- Going back by year, Non-Current Deffered Revenue was $405,000 in FY2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,157.52 Bn | 1,126.11 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 631.39 Bn | 549.92 Bn | 17.26 Bn | - |
| 3 | AbbVie | 498.93 Bn | 472.04 Bn | 12.70 Bn | - |
| 4 | Merck | 376.05 Bn | 330.42 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 301.98 Bn | 265.97 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 265.05 Bn | 238.74 Bn | 12.86 Bn | - |
| 7 | Amgen | 240.27 Bn | 195.67 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 193.08 Bn | 167.27 Bn | 6.22 Bn | - |
| 9 | Pfizer | 171.85 Bn | 118.50 Bn | 10.94 Bn | - |
| 10 | Connect Biopharma Holdings | 48.58 Mn | -128.10 Mn | - | - |
API Access
Connect Biopharma Holdings Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=CNTB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "CNTB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=CNTB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();